prednisolone sulfobenzoate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
prednisone and prednisolone derivatives 2250 630-67-1

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • prednisolone sulfobenzoate
  • prednisolone metasulfobenzoate
  • prednisolone metasulfobenzoate sodium
  • prednisolone sodium metasulfobenzoate
  • prednisolone metazoate
  • prednisolone sodium metazoate
  • Molecular weight: 544.62
  • Formula: C28H32O9S
  • CLOGP: 0.82
  • LIPINSKI: 1
  • HAC: 9
  • HDO: 3
  • TPSA: 155.27
  • ALOGS: -4.11
  • ROTB: 6

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

PropertyValueReference
S (Water solubility) 0.22 mg/mL Bocci G, Oprea TI, Benet LZ

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Urinary retention 69.63 51.94 22 716 30279 63458005
Hepatocellular injury 63.39 51.94 20 718 27361 63460923

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Fixed eruption 41.02 39.05 9 712 1691 34954519
Retinal artery occlusion 40.10 39.05 9 712 1876 34954334

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hepatocellular injury 68.09 35.04 28 1554 47565 79695241
Cholestasis 52.68 35.04 24 1558 52085 79690721
Fixed eruption 51.97 35.04 12 1570 2942 79739864
Urinary retention 47.72 35.04 23 1559 56607 79686199
Retinal artery occlusion 45.49 35.04 11 1571 3283 79739523
Hepatic cytolysis 42.31 35.04 17 1565 27134 79715672

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
FDA MoA N0000175450 Corticosteroid Hormone Receptor Agonists
FDA EPC N0000175576 Corticosteroid
MeSH PA D006728 Hormones
MeSH PA D000893 Anti-Inflammatory Agents
MeSH PA D000970 Antineoplastic Agents
MeSH PA D018931 Antineoplastic Agents, Hormonal
MeSH PA D005938 Glucocorticoids
CHEBI has role CHEBI:35472 anti-inflammatory drugs
CHEBI has role CHEBI:35610 antineoplastic agents
CHEBI has role CHEBI:35703 Xenobiotic
CHEBI has role CHEBI:35705 immunosuppressive agents
CHEBI has role CHEBI:37962 adrenergic agents
CHEBI has role CHEBI:49103 drug metabolites
CHEBI has role CHEBI:78298 environmental contaminants

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 12.78 acidic
pKa2 13.36 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D08413 KEGG_DRUG
3694-41-5 SECONDARY_CAS_RN
4017988 VANDF
CHEBI:135823 CHEBI
CHEBI:8378 CHEBI
TUA PDB_CHEM_ID
CHEMBL2111103 ChEMBL_ID
CHEMBL2107364 ChEMBL_ID
181625 PUBCHEM_CID
DB00860 DRUGBANK_ID
268872 RXNORM
5347 MMSL
59710 MMSL
d00084 MMSL
002155 NDDF
005522 NDDF
116601002 SNOMEDCT_US
52388000 SNOMEDCT_US
897039000 SNOMEDCT_US
C0889299 UMLSCUI
C0032950 UMLSCUI
535 INN_ID
5755 PUBCHEM_CID
D011239 MESH_DESCRIPTOR_UI
SR3YX73FW2 UNII

Pharmaceutical products:

None